1. Seol SY. Treatment of Helicobacter pylori infection. Korean J Med. 2006; 70:349–351.
2. Song HJ, Jung HC. Retreatment strategy of Hellcobacter pylori infection after initial treatment failure. Korean J Med. 2003; 65:272–276.
3. Rokkas T, Sechopoulos P, Robotis I, Margantinis G, Pistiolas D. Cumulative H. pylori eradication rates in clinical practice by adopting first and second-line regimens proposed by the Maastricht III consensus and a third-line empirical regimen. Am J Gastroenterol. 2009; 104:21–25.
4. Seo YH, Rhie SY, Park BJ, Kim HJ, Kim JG. Rescue therapies for Helicobacter pylori infection after failure of proton pump inhibitor-based standard triple therapy. Korean J Med. 2008; 74:23–29.
5. Cheon JH, Kim N, Lee DH, Kim JW, Hwang JH, Park YS, et al. Trial of moxifloxacin-containing triple therapy after initial and second-line treatment failures for Helicobacter pylori infection. Korean J Gastroenterol. 2005; 45:111–117.
6. Kim JH, Lee KT, Lee SM, Kim SH, Lee BS, Kim NJ, et al. Efficacy of ten days of clarithromycin, amoxicillin and omeprazole in eradicating Helicobacter pylori infection. Korean J Med. 1999; 56:581–589.
7. Kim JI, Chung IS, Bhang CS, Park SH, Choi MG, Kim JK, et al. Factors influencing eradication of Helicobacter pylori in patients with peptic ulcer disease. Korean J Gastroenterol. 1999; 33:624–634.
8. Park S, Cho SH, Choi KY, Chung IS, Chung KW, Sun HS, et al. Effect of single-dose vs. divided-dose drug administration on eradication of Helicobacter pylori in patients with peptic ulcers. Korean J Gastroenterol. 2000; 35:23–31.
9. Song HJ, Yang YS, Lee IS, Lee KM, Lee DS, Kim SW, et al. Efficacy and tolerability of pantoprazole-based triple therapy in eradication of Helicobacter pylori in patients with peptic ulcer and/or gastritis. Korean J Gastroenterol. 2000; 36:185–191.
10. Choi IJ, Jung HC, Choi KW, Kim JH, Ahn DS, Yang US, et al. Efficacy of low-dose clarithromycin triple therapy and tinidazole-containing triple therapy forfor Helicobacter pylori Eradication. Korean J Gastroenterol. 2001; 37:336–344.
11. Lee KM, Lee DS, Ahn BM, Song HJ, Kim SW, Han SW, et al. Effects of one - week triple therpy of ranitidine bismuth citrate, amoxicillin and clarithromycin in Helicobacter pylori-related peptic ulcer patients. Korean J Gastroenterol. 2001; 37:412–417.
12. Graham DY, Lew GM, Malaty HM, Evans DG, Evans DJ Jr, Klein PD, et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology. 1992; 102:493–496.
13. Nam SW, Roe IH, Kim SB, Lee BS, Hwang YJ, Park HJ, et al. Detection of clarithromycin-resistant Helicobacter pylori by polymerase chain reaction. Korean J Gastroenterol. 2000; 36:450–456.
14. Kim JJ, Reddy R, Lee M, Kim JG, El-Zaatari FA, Osato MS, et al. Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea. J Antimicrob Chemother. 2001; 47:459–461.
15. Cho DK, Park SY, Kee WJ, Lee JH, Ki HS, Yoon KW, et al. The trend of eradication rate of Helicobacter pylori infection and clinical factors that affect the eradication of first-line therapy. Korean J Gastroenterol. 2010; 55:368–375.
16. Kim JY, Kim N, Park HK, Jo HJ, Shin CM, Lee SH, et al. Primary antibiotic resistance of Helicobacter pylori strains and eradication rate according to gastroduodenal disease in korea. Korean J Gastroenterol. 2011; 58:74–81.